教育情况
医学学士，上海顺盈娱乐平台👟，临床医学🔒，2004年9月至2009年7月
内科学硕士，上海顺盈娱乐平台🧝🏼，内科学，2009年9月至2011年7月
内科学博士，上海顺盈娱乐平台与美国University of Georgia联合培养（国家公派留学生）✫，内科学，2011年9月至2014年6月
承担基金
2022年，上海市2022年度“科技创新行动计划”医学创新研究专项项目𓀊，一项评价超声引导下热消融治疗原发性甲状旁腺功能亢进症安全性和有效性的研究，项目负责人，项目编号🚴🏽：22Y11904900，经费🛠：30万元，2022年7月1日至2025年6月30日👩👦👦。
2021年😰，临床研究项目🌞，一项单中心2型糖尿病患者血管病变与骨质疏松患病风险的队列研究👨🏿🦲，项目负责人🦴，项目编号：YNCR2C001，经费🎦：10万元🧔🏽♂️，2022年1月至2024年12月。
2021年，教学课题🖇，慕课教学在新型冠状病毒肺炎期间应用于医学教育的探索👨🏿💻，项目负责人，项目编号🏍：2021-A-2🫰🏽，经费：0.8万元🥡，2021 年12 月1 日至2023 年10 月31 日。
2021年，党建立项课题，党建工作与临床业务相互促进🧖🏽♂️、共同发展模式探索研究，项目负责人，项目编号：2021DJLX09，经费🌧🔢：0.5万元🤜🏻，2021年7月至2023年4月。
2018年🐙，上海市第十人民医院攀登人才计划，糖尿病血管病变与骨密度相关性的临床和基础研究，项目负责人，项目编号：2018SYPDRC049，经费：6万元，2018年9月至2020年8月。
2015年，国家自然科学基金，超氧化物歧化酶3对肥胖症的干预作用及其机制研究，项目负责人，项目编号：81500650，经费：18万元，2016年1月至2018年12月。
2015年，上海顺盈娱乐平台优秀青年基金，超氧化物歧化酶3对肥胖的治疗作用及其机制研究，项目负责人👮🏿♀️，项目编号🕹：2015KJ053，经费：1.5万元，2016年1月至2018年12月💆🏿。
2010年👩🏼🌾，上海顺盈娱乐平台《聚焦糖尿病》，项目负责人，经费💃🏽：0.2元，2011年10月至2012年10月☠️。
部分发表文章
（#第一作者，*通讯作者）
1. Ran C (#), Xiaojuan X, Wenxue G (*), Zhaoliang F (*), Hui S (*), Shen Q. Sexual dimorphism in the relation between sex hormones and osteoporosis in patients with type 2 diabetes mellitus. Journal of bone and mineral metabolism. 2022 May;40(3):460-467. doi: 10.1007/s00774-021-01291-6. Epub 2022 Feb 2. PMID: 35106610. （IF=2.976）
2. Cai M (#), Cui R (#), Yang P (#), Gao J, Cheng X, Sheng C, Li H, Sheng H, Qu S, Zhang M (*). Incidence and Risk Factors of Hypogonadism in Male Patients With Latent Autoimmune Diabetes and Classic Type 2 Diabetes. Frontiers in Endocrinology. 2021 May 31;12:675525. doi: 10.3389/fendo.2021.675525. PMID: 34135863; PMCID: PMC8202076. （IF=6.055）
3. Xu X (#), Zhang M (#), Fei Z, Sheng H, Qu S, Cui R (*). Calcification of lower extremity arteries is related to the presence of osteoporosis in postmenopausal women with type 2 diabetes mellitus: a cross-sectional observational study. Osteoporosis International. 2021 Jun;32(6):1185-1193. doi: 10.1007/s00198-020-05775-5. Epub 2021 Jan 7. PMID: 33411011; PMCID: PMC8128735. (IF=5.017)
4. Fei Z (#), Gao W (#), Xu X, Sheng H, Qu S, Cui R (*). Serum superoxide dismutase activity: a sensitive, convenient, and economical indicator associated with the prevalence of chronic type 2 diabetic complications, especially in men. Free Radical Research. 2021 Mar;55(3):275-281. doi: 10.1080/10715762.2021.1937146. Epub 2021 Jun 14. PMID: 34082660. （IF=4.354）
5. Cui R (#), Fei Z (*), Li Y (*), Gao W (*). Anemia is related to osteoporosis in Chinese type 2 diabetic patients. Archives of osteoporosis. 2021 Oct 30;16(1):161. doi: 10.1007/s11657-021-01030-4. PMID: 34716464. (IF=2.879)
6. Cui R (#), Sun S Q (#), Zhong N (#), Sheng H (*), et al. The relationship between atherosclerosis and bone mineral density in patients with type 2 diabetes depends on vascular calcifications and sex. Osteoporosis International, 2020 Jun;31(6):1135-1143. doi: 10.1007/s00198-020-05374-4. Epub 2020 Mar 10. （IF=5.017）
7. Zhong N (#), Cui R (*), Sheng H (*), et al. Microangiopathy is associated with bone loss in female type 2 diabetes mellitus patients. Diabetes and Vascular Disease Research, 2018,Sep 15(5):433-441 (IF=3.541)
8. Zhu CL (#), Cui R (*), Qu S (*), et al. The Associations of Serum Uric Acid with Obesity-Related Acanthosis nigricans and Related Metabolic Indices. International Journal of Endocrinology, 2017, 5438157 (DOI: 10.1155/2017/5438157). (IF=3.257)
9. Cui R (#), Gao MM, Liu DX (*), et al. Overexpression of superoxide dismutase 3 gene blocks high-fat diet-induced obesity, fatty liver and insulin resistance. Gene Therapy, 2014,21(9):840-848. (IF=5.25)
10. Cui R (#), Sheng H (*), Qu Shen, et al. Total osteocalcin in serum predicts testosterone level in male type 2 diabetes mellitus. International Journal of Clinical and Experimental Medicine, 2014, 7(4):1145-1149. (IF=1.422)
11. Cui R (#), Rui XF, Sheng H (*), et al. Low Bone Mineral Density in Chinese Adults with Nonalcoholic Fatty Liver Disease. International Journal of Endocrinology, 2013, 396545(DOI: 10.1155/2013/396545). (IF=3.257)
EducationBachelor of Science, Clinical Medicine, School of Medicine, Tongji University, September 2004 to July 2009
Master of Science, Endocrinology & Metabolism in Internal Medicine, School of Medicine, Tongji University, September 2009 to July 2011
Doctor of Science, Endocrinology & Metabolism in Internal Medicine, School of Medicine, Tongji University, September 2011 to June 2014
Grant
Cui Ran (PI), Science and Technology Commission of Shanghai Municipality (22Y11904900).
Cui Ran (PI), Shanghai Tenth People’s Hospital of Tongji University (YNCR2C001).
Cui Ran (PI), Shanghai Tenth People’s Hospital of Tongji University (2021-A-2).
Cui Ran (PI), Shanghai Tenth People’s Hospital of Tongji University (2021DJLX09).
Cui Ran (PI), Shanghai Tenth People’s Hospital of Tongji University (2018SYPDRC049).
Cui Ran (PI), National Natural Science Foundation of China (81500650).
Cui Ran (PI), Tongji University Foundation for Distinguished Young Scholars (2015KJ053).
Cui Ran (PI), Tongji University Foundation for Focusing on Diabetes ellitus.
Selected publications1. Ran C (#), Xiaojuan X, Wenxue G (*), Zhaoliang F (*), Hui S (*), Shen Q. Sexual dimorphism in the relation between sex hormones and osteoporosis in patients with type 2 diabetes mellitus. Journal of bone and mineral metabolism. 2022 May;40(3):460-467. doi: 10.1007/s00774-021-01291-6. Epub 2022 Feb 2. PMID: 35106610. （IF=2.976）
2. Cai M (#), Cui R (#), Yang P (#), Gao J, Cheng X, Sheng C, Li H, Sheng H, Qu S, Zhang M (*). Incidence and Risk Factors of Hypogonadism in Male Patients With Latent Autoimmune Diabetes and Classic Type 2 Diabetes. Frontiers in Endocrinology. 2021 May 31;12:675525. doi: 10.3389/fendo.2021.675525. PMID: 34135863; PMCID: PMC8202076. （IF=6.055）
3. Xu X (#), Zhang M (#), Fei Z, Sheng H, Qu S, Cui R (*). Calcification of lower extremity arteries is related to the presence of osteoporosis in postmenopausal women with type 2 diabetes mellitus: a cross-sectional observational study. Osteoporosis International. 2021 Jun;32(6):1185-1193. doi: 10.1007/s00198-020-05775-5. Epub 2021 Jan 7. PMID: 33411011; PMCID: PMC8128735. (IF=5.017)
4. Fei Z (#), Gao W (#), Xu X, Sheng H, Qu S, Cui R (*). Serum superoxide dismutase activity: a sensitive, convenient, and economical indicator associated with the prevalence of chronic type 2 diabetic complications, especially in men. Free Radical Research. 2021 Mar;55(3):275-281. doi: 10.1080/10715762.2021.1937146. Epub 2021 Jun 14. PMID: 34082660. （IF=4.354）
5. Cui R (#), Fei Z (*), Li Y (*), Gao W (*). Anemia is related to osteoporosis in Chinese type 2 diabetic patients. Archives of osteoporosis. 2021 Oct 30;16(1):161. doi: 10.1007/s11657-021-01030-4. PMID: 34716464. (IF=2.879)
6. Cui R (#), Sun S Q (#), Zhong N (#), Sheng H (*), et al. The relationship between atherosclerosis and bone mineral density in patients with type 2 diabetes depends on vascular calcifications and sex. Osteoporosis International, 2020 Jun;31(6):1135-1143. doi: 10.1007/s00198-020-05374-4. Epub 2020 Mar 10. （IF=5.017）
7. Zhong N (#), Cui R (*), Sheng H (*), et al. Microangiopathy is associated with bone loss in female type 2 diabetes mellitus patients. Diabetes and Vascular Disease Research, 2018,Sep 15(5):433-441 (IF=3.541)
8. Zhu CL (#), Cui R (*), Qu S (*), et al. The Associations of Serum Uric Acid with Obesity-Related Acanthosis nigricans and Related Metabolic Indices. International Journal of Endocrinology, 2017, 5438157 (DOI: 10.1155/2017/5438157). (IF=3.257)
9. Cui R (#), Gao MM, Liu DX (*), et al. Overexpression of superoxide dismutase 3 gene blocks high-fat diet-induced obesity, fatty liver and insulin resistance. Gene Therapy, 2014,21(9):840-848. (IF=5.25)
10. Cui R (#), Sheng H (*), Qu Shen, et al. Total osteocalcin in serum predicts testosterone level in male type 2 diabetes mellitus. International Journal of Clinical and Experimental Medicine, 2014, 7(4):1145-1149. (IF=1.422)
11. Cui R (#), Rui XF, Sheng H (*), et al. Low Bone Mineral Density in Chinese Adults with Nonalcoholic Fatty Liver Disease. International Journal of Endocrinology, 2013, 396545(DOI: 10.1155/2013/396545). (IF=3.257)
（#first author, *corresponding author）
